116 related articles for article (PubMed ID: 26386137)
1. Fatty acid modified octa-arginine for delivery of siRNA.
Li Y; Li Y; Wang X; Lee RJ; Teng L
Int J Pharm; 2015 Nov; 495(1):527-535. PubMed ID: 26386137
[TBL] [Abstract][Full Text] [Related]
2. Delivery of siRNA Using Cationic Liposomes Incorporating Stearic Acid-modified Octa-Arginine.
Yang D; Li Y; Qi Y; Chen Y; Yang X; Li Y; Liu S; Lee RJ
Anticancer Res; 2016 Jul; 36(7):3271-6. PubMed ID: 27354583
[TBL] [Abstract][Full Text] [Related]
3. Liposomes Incorporating Transferrin and Stearic Acid-modified Octa-arginine for siRNA Delivery.
Yang D; Yang X; Lee RJ; Liu S; Xie J
Anticancer Res; 2017 Apr; 37(4):1759-1764. PubMed ID: 28373438
[TBL] [Abstract][Full Text] [Related]
4. HA-Modified R8-Based Bola-Amphiphile Nanocomplexes for Effective Improvement of siRNA Delivery Efficiency.
Jia N; Ma J; Gao Y; Hu H; Chen D; Zhao X; Yuan Y; Qiao M
ACS Biomater Sci Eng; 2020 Apr; 6(4):2084-2093. PubMed ID: 33455327
[TBL] [Abstract][Full Text] [Related]
5. [Cell penetrating peptides enhance intracellular translocation and function of siRNA encapsulated in Pegylated liposomes].
Wang W; Tang N; Zhang CL; Liu XJ; Hu H; Zhang ZX; Liang W
Yao Xue Xue Bao; 2006 Feb; 41(2):142-8. PubMed ID: 16671545
[TBL] [Abstract][Full Text] [Related]
6. Delivery of siRNA Using Lipid Nanoparticles Modified with Cell Penetrating Peptide.
Li Y; Lee RJ; Yu K; Bi Y; Qi Y; Sun Y; Li Y; Xie J; Teng L
ACS Appl Mater Interfaces; 2016 Oct; 8(40):26613-26621. PubMed ID: 27617513
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
[TBL] [Abstract][Full Text] [Related]
8. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
Golan M; Feinshtein V; David A
Eur J Pharm Biopharm; 2016 Dec; 109():103-112. PubMed ID: 27702685
[TBL] [Abstract][Full Text] [Related]
9. Antilung cancer effect of ergosterol and cisplatin-loaded liposomes modified with cyclic arginine-glycine-aspartic acid and octa-arginine peptides.
Wu M; Huang T; Wang J; Chen P; Mi W; Ying Y; Wang H; Zhao D; Huang S
Medicine (Baltimore); 2018 Aug; 97(33):e11916. PubMed ID: 30113492
[TBL] [Abstract][Full Text] [Related]
10. Improving the efficacy of liposome-mediated vascular gene therapy via lipid surface modifications.
Fisher RK; Mattern-Schain SI; Best MD; Kirkpatrick SS; Freeman MB; Grandas OH; Mountain DJH
J Surg Res; 2017 Nov; 219():136-144. PubMed ID: 29078873
[TBL] [Abstract][Full Text] [Related]
11. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
[TBL] [Abstract][Full Text] [Related]
13. Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis.
Zhao J; Zhang X; Sun X; Zhao M; Yu C; Lee RJ; Sun F; Zhou Y; Li Y; Teng L
Eur J Pharm Biopharm; 2018 Sep; 130():39-47. PubMed ID: 29928978
[TBL] [Abstract][Full Text] [Related]
14. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene.
Zhang C; Tang N; Liu X; Liang W; Xu W; Torchilin VP
J Control Release; 2006 May; 112(2):229-39. PubMed ID: 16545478
[TBL] [Abstract][Full Text] [Related]
15. Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy.
Kara G; Parlar A; Cakmak MC; Cokol M; Denkbas EB; Bakan F
Colloids Surf B Biointerfaces; 2020 Dec; 196():111340. PubMed ID: 32956996
[TBL] [Abstract][Full Text] [Related]
16. Polyethylene glycol and octa-arginine dual-functionalized nanographene oxide: an optimization for efficient nucleic acid delivery.
Imani R; Prakash S; Vali H; Faghihi S
Biomater Sci; 2018 May; 6(6):1636-1650. PubMed ID: 29757340
[TBL] [Abstract][Full Text] [Related]
17. Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA nanocomplexes for anti-melanoma treatment.
Ruan W; Zhai Y; Yu K; Wu C; Xu Y
Int J Pharm; 2018 Dec; 553(1-2):298-309. PubMed ID: 30347273
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared boosted ROS responsive siRNA delivery and cancer therapy with sequentially peeled upconversion nano-onions.
He Y; Guo S; Wu L; Chen P; Wang L; Liu Y; Ju H
Biomaterials; 2019 Dec; 225():119501. PubMed ID: 31561086
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
20. Peptide-Based Nanoparticles to Rapidly and Efficiently "Wrap 'n Roll" siRNA into Cells.
Konate K; Dussot M; Aldrian G; Vaissière A; Viguier V; Neira IF; Couillaud F; Vivès E; Boisguerin P; Deshayes S
Bioconjug Chem; 2019 Mar; 30(3):592-603. PubMed ID: 30586303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
